Prakiraan rega marang bathi: Neurogene Corp (NGNE)
Neurogene Inc. (NGNE) specializes in developing gene therapies for the treatment of nervous system disorders. This daily price chart reflects a P/E ratio of 0.00. Positive investor sentiment is driven by successful interim tests for the treatment of Rett syndrome. The business model relies on high patent profitability, where primary costs are concentrated in research, while subsequent global rollout requires minimal investment.
NGNE (Neurogene Therapeutics): rincian analitis lan laporan miturut indikator
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Neurogene Inc.|NGNE - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Neurogene Inc.|NGNE - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Neurogene Inc|NGNE - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Neurogene|Indikator likuiditas cepet neurogene.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
NGNE - Bathi pungkasan|Proyeksi bathi mangsa ngarep Neurogene Inc.|NGNE - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Neurogene Corp|NGNE - Rasio P/E diaturake wutah|Pangali EV/EBITDA Neurogene Inc|NGNE - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Neurogene|NGNE - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan neurogene.com|NGNE - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Neurogene Inc.
- informasi babagan volume dodolan lan pendapatan:
Analisis kabeh metrik perusahaan:NGNE Neurogene
Neurogene Inc. (NGNE) creates high asset market value through complex R&D developments and patents in the field of gene therapy. Investors bake this potential into the forward P/E, calculated as the ratio of current market capitalization to expected net income. This metric reflects the market's willingness to pay a premium for future success in clinical trials. By analyzing changes in the company's forward price-to-earnings multiple, one can assess the stability of confidence in the commercialization of its drugs. A decline in this indicator signals rising risks of failing to achieve financial targets.
Karo sapa Neurogene Inc. saingan
Pangali Forward P/E BIIB|NBIX - Rasio prakiraan rega marang bathi|Regencell - Prakiraan rega marang bathi|Pangali Forward P/E Axsome Corp AXSM|ACAD - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi XENE (xenon-pharma.com)|Viking Therapeutics, Inc. (VKTX) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Supernus Pharmaceuticals, Inc. (SUPN)|CPRX (Catalyst Pharmaceuticals Inc) - Pangali Forward P/E|DNLI - Pangali forward rega marang bathi|Pangali Forward P/E HRMY|BHVN - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Rasio rega marang bathi mangsa ngarep|Praxis Medicines - Pangali Forward P/E|Rasio prakiraan rega marang bathi Anavex Life Sciences Corp|CBLL (CeriBell, Inc.) - Prakiraan rega marang bathi|Prothena - Pangali mangsa ngarep rega marang bathi|ALEC (Alector Inc.) - Pangali Forward P/E|Annexon Biosciences (ANNX) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Omeros Corporation (OMER)|AC Immune Inc - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VYGR (Voyager Therapeutics)|NMRA - Prakiraan rega marang bathi|SCLX: Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi Tevogen Bio Holdings Inc. TVGN|alphacognition.com (ACOG) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep CGTX|IKT (Inhibikase Therapeutics) - Pangali Forward P/E|SAVA - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep Assertio Holdings, Inc. (ASRT)|coyatherapeutics.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Rasio prakiraan rega marang bathi|ABOS - Rega marang bathi mangsa ngarep|CRVO (cervomed.com) - Rasio rega marang bathi mangsa ngarep|ATHE: Pangali Forward P/E|Rasio prakiraan rega marang bathi Clene (CLNN)|Prakiraan rega marang bathi PEPG|Pangali Forward P/E Jupiter Neurosciences, Inc.|Rega marang bathi mangsa ngarep Relmada Therapeutics (RLMD)|ANVS (annovisbio.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Grace Therapeutics GRCE|Firefly Neuroscience, Inc. (AIFF) - Rasio prakiraan rega marang bathi|KLTO - Rega marang bathi mangsa ngarep|NRSN (NeuroSense Therapeutics) - Rasio rega marang bathi mangsa ngarep|RVPH: Pangali Forward P/E|Rasio prakiraan rega marang bathi MetaVia (MTVA)|Prakiraan rega marang bathi NRXS|Pangali Forward P/E Helius Medical Technologies Inc.|Rega marang bathi mangsa ngarep Passage Bio, Inc. (PASG)|NEUP (bionomics.com.au) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Minerva Neurosciences NERV|athira.com (ATHA) - Rasio prakiraan rega marang bathi|Addex Therapeutics Ltd - Pangali Forward P/E|Pangali forward rega marang bathi Alzamend Neuro, Inc. (ALZN)|CYCN: Pangali Forward P/E|Rasio prakiraan rega marang bathi Protagenic Therapeutics, Inc. (PTIX)|Rega marang bathi mangsa ngarep Pasithea Therapeutics Corp|Rasio rega marang bathi mangsa ngarep CRGT (Cortigent Medical)|Pangali Forward P/E ATXI|BCLI - Rasio prakiraan rega marang bathi|Cara Therapeutics, Inc - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CHRO|Eliem - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Intra-Cellular Therapies ITCI|Longboard Pharmaceuticals, Inc. (LBPH) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep MRNS|NKGN (NKGen) - Pangali Forward P/E|Prakiraan rega marang bathi NeuroBo Pharma (NRBO)|Prakiraan rega marang bathi SAGE (Sage Therapeutics, Inc.)|Kapitalisasi marang proyeksi bathi synaptogen.com|Rega marang bathi mangsa ngarep Trevena TRVN|VIGL: Rasio rega marang bathi mangsa ngarep|Anew Medical - Pangali Forward P/E|Pangali forward rega marang bathi Cerevel Corp (CERE)
